HyperHEP B
STN:101146
Proper Name: Hepatitis B Immune Globulin (Human)
Trade Name: HyperHEP B
Manufacturer: Grifols Therapeutics LLC
Indication:
HyperHEP B is indicated for post-exposure prophylaxis in the following situations: (1) acute exposure to blood containing HBsAg after either parenteral exposure (e.g., accidental "needlestick") or direct mucous membrane contact (accidental splash), or oral ingestion (pipetting accident) involving HBsAg-positive materials such as blood, plasma, or serum; (2) perinatal exposure of infants born to HBsAg-positive mothers; (3) sexual exposure to an HBsAg-positive person; and (4) household exposure to persons with acute HBV infection for infants less than 12 months of age when the mother or primary care-giver has acute HBV infection.